Back to Search
Start Over
Lost in translation: returning germline genetic results in genome-scale cancer research
- Source :
- Genome Medicine, Vol 9, Iss 1, Pp 1-9 (2017), Genome Medicine
- Publication Year :
- 2017
- Publisher :
- BMC, 2017.
-
Abstract
- Background The return of research results (RoR) remains a complex and well-debated issue. Despite the debate, actual data related to the experience of giving individual results back, and the impact these results may have on clinical care and health outcomes, is sorely lacking. Through the work of the Australian Pancreatic Cancer Genome Initiative (APGI) we: (1) delineate the pathway back to the patient where actionable research data were identified; and (2) report the clinical utilisation of individual results returned. Using this experience, we discuss barriers and opportunities associated with a comprehensive process of RoR in large-scale genomic research that may be useful for others developing their own policies. Methods We performed whole-genome (n = 184) and exome (n = 208) sequencing of matched tumour-normal DNA pairs from 392 patients with sporadic pancreatic cancer (PC) as part of the APGI. We identified pathogenic germline mutations in candidate genes (n = 130) with established predisposition to PC or medium–high penetrance genes with well-defined cancer associated syndromes or phenotypes. Variants from candidate genes were annotated and classified according to international guidelines. Variants were considered actionable if clinical utility was established, with regard to prevention, diagnosis, prognostication and/or therapy. Results A total of 48,904 germline variants were identified, with 2356 unique variants undergoing annotation and in silico classification. Twenty cases were deemed actionable and were returned via previously described RoR framework, representing an actionable finding rate of 5.1%. Overall, 1.78% of our cohort experienced clinical benefit from RoR. Conclusion Returning research results within the context of large-scale genomics research is a labour-intensive, highly variable, complex operation. Results that warrant action are not infrequent, but the prevalence of those who experience a clinical difference as a result of returning individual results is currently low. Electronic supplementary material The online version of this article (doi:10.1186/s13073-017-0430-4) contains supplementary material, which is available to authorized users.
- Subjects :
- Adult
0301 basic medicine
Candidate gene
lcsh:QH426-470
DNA Mutational Analysis
lcsh:Medicine
Context (language use)
Genomics
Return of results
Bioinformatics
Research ethics
03 medical and health sciences
0302 clinical medicine
Germline mutation
Genetics
Genomic data
Humans
Medicine
Computer Simulation
Genetic Predisposition to Disease
Molecular Biology
Exome
Germ-Line Mutation
Genetics (clinical)
Aged
Aged, 80 and over
Whole-genome sequencing
Genome, Human
business.industry
Research
lcsh:R
Australia
Middle Aged
Penetrance
Human genetics
3. Good health
Pancreatic Neoplasms
lcsh:Genetics
030104 developmental biology
030220 oncology & carcinogenesis
Molecular Medicine
business
Subjects
Details
- Language :
- English
- Volume :
- 9
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Genome Medicine
- Accession number :
- edsair.doi.dedup.....0937116ad528506af16b017843a93dd6